Steven Bellon

2022

In 2022, Steven Bellon earned a total compensation of $2.1M as Chief Scientific Officer at Foghorn Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$130,500
Option Awards$1,580,167
Salary$435,000
Total$2,145,667

Bellon received $1.6M in option awards, accounting for 74% of the total pay in 2022.

Bellon also received $130.5K in non-equity incentive plan and $435K in salary.

Rankings

In 2022, Steven Bellon's compensation ranked 1,657th out of 5,694 executives tracked by ExecPay. In other words, Bellon earned more than 70.9% of executives.

ClassificationRankingPercentile
All
1,657
out of 5,694
71st
Division
Manufacturing
858
out of 3,099
72nd
Major group
Chemicals And Allied Products
338
out of 1,406
76th
Industry group
Drugs
312
out of 1,307
76th
Industry
Pharmaceutical Preparations
222
out of 953
77th
Source: SEC filing on May 3, 2024.

Bellon's colleagues

We found one more compensation record of an executive who worked with Steven Bellon at Foghorn Therapeutics in 2022.

2022

Adrian Gottschalk

Foghorn Therapeutics

Chief Executive Officer

News

In-depth

You may also like